Monding, Angelika G.

HRN: 27-68-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
CEFUROXIME 1.5GM (VIAL)
08/22/2025
08/23/2025
IV
1.5gm
Q8hr X 2 Doses
Sp Pelvic Lap
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines